These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8205659)

  • 1. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia.
    Egashira K; Hirooka Y; Kai H; Sugimachi M; Suzuki S; Inou T; Takeshita A
    Circulation; 1994 Jun; 89(6):2519-24. PubMed ID: 8205659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol lowering with pravastatin improves resistance artery endothelial function: report of six subjects with normal coronary arteriograms.
    Houghton JL; Pearson TA; Reed RG; Torosoff MT; Henches NL; Kuhner PA; Philbin EF
    Chest; 2000 Sep; 118(3):756-60. PubMed ID: 10988199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Improvement of endothelial function in patients with hypercholesterolemia and normal coronary arteries with lipid-lowering therapy].
    Iràculis E; Cequier A ; Sabaté M; Pintó X; Antoni Gómez-Hospital J; Mauri J; García Del Blanco B; Fernández-Nofrerias E; Palom X; Jara F; Esplugas E
    Rev Esp Cardiol; 2001 Jun; 54(6):685-92. PubMed ID: 11412774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function.
    Wassmann S; Faul A; Hennen B; Scheller B; Böhm M; Nickenig G
    Circ Res; 2003 Oct; 93(9):e98-103. PubMed ID: 14551237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits of lipid lowering on vascular reactivity in patients with coronary artery disease and average cholesterol levels: a mechanism for reducing clinical events?
    Cohen JD; Drury JH; Ostdiek J; Finn J; Babu BR; Flaker G; Belew K; Donohue T; Labovitz A
    Am Heart J; 2000 Apr; 139(4):734-8. PubMed ID: 10740160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired endothelium-dependent vasodilation of coronary resistance vessels in hypercholesterolemic patients.
    Shiode N; Kato M; Hiraoka A; Yamagata T; Matsuura H; Kajiyama G
    Intern Med; 1996 Feb; 35(2):89-93. PubMed ID: 8680111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simvastatin and pravastatin equally improve flow-mediated dilation in males with hypercholesterolemia.
    Sebestjen M; Boh M; Keber I
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):999-1003. PubMed ID: 12635468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of endothelium-dependent coronary vasodilation after a single LDL apheresis in patients with hypercholesterolemia.
    Igarashi K; Tsuji M; Nishimura M; Horimoto M
    J Clin Apher; 2004; 19(1):11-6. PubMed ID: 15095396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients.
    Leung WH; Lau CP; Wong CK
    Lancet; 1993 Jun; 341(8859):1496-500. PubMed ID: 8099379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial function in human coronary arteries in vivo. Focus on hypercholesterolemia.
    Drexler H; Zeiher AM
    Hypertension; 1991 Oct; 18(4 Suppl):II90-9. PubMed ID: 1917002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis.
    Zeiher AM; Drexler H; Wollschläger H; Just H
    Circulation; 1991 Feb; 83(2):391-401. PubMed ID: 1991363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial.
    Dupuis J; Tardif JC; Cernacek P; Théroux P
    Circulation; 1999 Jun; 99(25):3227-33. PubMed ID: 10385495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion.
    Anderson TJ; Meredith IT; Yeung AC; Frei B; Selwyn AP; Ganz P
    N Engl J Med; 1995 Feb; 332(8):488-93. PubMed ID: 7830729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension.
    Zeiher AM; Drexler H; Saurbier B; Just H
    J Clin Invest; 1993 Aug; 92(2):652-62. PubMed ID: 8349804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lipid-lowering therapy with pravastatin on myocardial blood flow in young mildly hypercholesterolemic adults.
    Janatuinen T; Laaksonen R; Vesalainen R; Raitakari O; Lehtimäki T; Nuutila P; Knuuti J
    J Cardiovasc Pharmacol; 2001 Oct; 38(4):561-8. PubMed ID: 11588526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise-induced vasomotion of angiographically normal and stenotic coronary arteries improves after cholesterol-lowering drug therapy with bezafibrate.
    Seiler C; Suter TM; Hess OM
    J Am Coll Cardiol; 1995 Dec; 26(7):1615-22. PubMed ID: 7594094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of age on endothelium-dependent vasodilation of resistance coronary artery by acetylcholine in humans.
    Egashira K; Inou T; Hirooka Y; Kai H; Sugimachi M; Suzuki S; Kuga T; Urabe Y; Takeshita A
    Circulation; 1993 Jul; 88(1):77-81. PubMed ID: 8319359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans.
    Anderson TJ; Meredith IT; Charbonneau F; Yeung AC; Frei B; Selwyn AP; Ganz P
    Circulation; 1996 May; 93(9):1647-50. PubMed ID: 8653869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis.
    Zeiher AM; Drexler H; Wollschläger H; Just H
    Circulation; 1991 Nov; 84(5):1984-92. PubMed ID: 1934373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic changes associated with reduction in total cholesterol by treatment with the HMG-CoA reductase inhibitor pravastatin.
    Muramatsu J; Kobayashi A; Hasegawa N; Yokouchi S
    Atherosclerosis; 1997 Apr; 130(1-2):179-82. PubMed ID: 9126662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.